Aktienanalyse zu Huron Consulting Group Inc (HURN)HURNHuron Consulting Group Inc

Huron Consulting Group Inc. is a global professional service. The Company operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Its products include TriZetto’s Facets, QNXT, and HealthEdge solutions. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).

Huron Consulting Group Inc is a good buy right now due to its strong recent earnings performance, with Q2 2026 earnings per share reported at $2.46, exceeding estimates by 15.49%. Additionally, the forward P/E ratio of 17.57 suggests the stock is undervalued compared to its growth potential. The main risk is the recent insider selling, which has increased by 196.55%, indicating potential concerns among insiders about the stock's future performance.

4 analysts cover HURN: 2 rate it Buy, 2 Hold and 0 Sell. The average price target is 211.00.